U.S. markets open in 5 hours 39 minutes
  • S&P Futures

    4,459.00
    +13.25 (+0.30%)
     
  • Dow Futures

    34,816.00
    +142.00 (+0.41%)
     
  • Nasdaq Futures

    15,350.75
    +32.00 (+0.21%)
     
  • Russell 2000 Futures

    2,254.20
    +10.20 (+0.45%)
     
  • Crude Oil

    74.74
    +0.76 (+1.03%)
     
  • Gold

    1,757.30
    +5.60 (+0.32%)
     
  • Silver

    22.37
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1703
    -0.0015 (-0.13%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    17.84
    -0.79 (-4.24%)
     
  • GBP/USD

    1.3685
    +0.0004 (+0.03%)
     
  • USD/JPY

    110.7200
    +0.0350 (+0.03%)
     
  • BTC-USD

    43,862.30
    +2,720.36 (+6.61%)
     
  • CMC Crypto 200

    1,093.28
    -9.78 (-0.89%)
     
  • FTSE 100

    7,088.72
    +37.24 (+0.53%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

(CHNG) Alert: Johnson Fistel Investigates Proposed Sale of Change Healthcare; Is $25.75 a Fair Price?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Change Healthcare (NASDAQ: CHNG) breached their fiduciary duties in connection with the proposed sale of the Company to UnitedHealth Group (NYSE: UNH) ("UnitedHealth").

On January 4, 2021, Change Healthcare announced that it had entered into a definitive merger agreement with UnitedHealth. Under the terms of the deal, Change Healthcare stockholders will receive $ 25.75 per share in cash.

The investigation concerns whether the Change Healthcare board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Change Healthcare shares of common stock.

If you are a shareholder of Change Healthcare and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[Click here to join this action]

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/chng-alert-johnson-fistel-investigates-proposed-sale-of-change-healthcare-is-25-75-a-fair-price-301201986.html

SOURCE Johnson Fistel, LLP